On February 17, 2017, we published an article titled ‘Who’s entering Antangin (Deltomed)?’. In the article, we speculated on an investment company. Yesterday, Saratoga Investama Sedaya (SRTG), investment company controlled by tycoon Edwin Soeryadjaya, informed market participants that its subsidiary PT Saratoga Sentra Business (SSB) has acquired minority shareholding in PT Deltomed Laboratories, producer of Antangin JRG, a herbal remedy for the common cold, for Rp85.7 billion.To subscribe please click here